How effective is Trodelvy and what's the success rate?
Does Trodelvy shrink tumors?
Trodelvy (sacituzumab govitecan-hziy) is a targeted chemotherapy drug that may be used to treat the following cancers that have spread (metastasized) or cannot be removed by surgery:
- triple-negative breast cancer (negative for estrogen and progesterone hormone receptors and HER2 [TNBC]) who have received at least 2 prior treatments, including at least one for metastatic disease.
- hormone receptor-positive and human epidermal growth factor receptor 2-negative (HR+/HER2-) breast cancer who have previously received endocrine therapy and at least 2 additional treatments for metastatic disease.
Treatment with Trodelvy aims to increase the length of time a patient lives, and also how long they live without their cancer progressing. For most of these cancers, few other treatments are available.
How effective is Trodelvy for triple-negative breast cancer?
In patients with TNBC, whose cancer had not spread to the brain, treatment with Trodelvy resulted in significantly longer progression-free survival (5.6 vs. 1.7 months) and overall survival (12.1 vs. 6.7 months) compared with patients treated with the physician’s choice of single-agent chemotherapy (eribulin, vinorelbine, capecitabine, or gemcitabine), according to the results of the phase III ASCENT trial.
More of the patients in the ASCENT trial treated with Trodelvy also successfully responded to treatment compared with patients who received single-agent chemotherapy (35 vs. 5 percent). In a separate study called IMMU-132-01, which enrolled 108 patients with TNBC who had received between 2 and 10 previous treatments, 33.3 percent of patients responded to treatment with Trodelvy. Median progression-free survival and overall survival in these patients was 5.5 and 13 months, respectively.
How effective is Trodelvy for pre-treated HR+/HER2- metastatic breast cancer?
A statistically significant and clinically meaningful overall survival (OS) benefit of 3.2 months was reported for Trodelvy vs. single-agent chemotherapy (treatment of physician’s choice; TPC) (median OS: 14.4 months vs. 11.2 months; hazard ratio [HR]=0.79; 95% CI: 0.65-0.96; p=0.02) in the TROPiCS-02 study. Trodelvy also demonstrated a 34% reduction in risk of disease progression or death (median PFS: 5.5 versus 4.0 months; HR: 0.66; 95% CI: 0.53-0.83; p=0.0003). Three times as many people treated with Trodelvy were progression-free at one year versus those treated with chemotherapy (21% versus 7%). Secondary endpoint measures, including objective response rate and time to deterioration (TTD), were also significantly improved by Trodelvy.
Trodelvy is now recommended as a Category 1, preferred treatment for metastatic HR+/HER2- breast cancer by the National Comprehensive Cancer Network (NCCN).
Related questions
- What is the strongest chemotherapy drug for breast cancer?
- Why are my nipples sore? 7 possible causes
- How long do letrozole side effects last?
Does Trodelvy shrink tumors?
Trodelvy may shrink the size of your tumors. In the ASCENT trial conducted on patients with TNBC, about 4 percent had their tumors completely disappear (complete response) and about 31 percent had a partial response.
In addition to the patients who benefit from the tumor-shrinking effects of Trodelvy, other patients also derive a clinical benefit from taking this drug because it keeps their disease stable - meaning that their tumors stay about the same size for some time instead of getting worse.
Trodelvy has been approved by the US Food and Drug Administration (FDA) to treat:
- TNBC that has spread or is locally advanced and unable to be removed with surgery in people who have been treated with two or more other therapies, including at least one for treating metastatic disease
- Unresectable locally advanced or metastatic hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative (IHC 0, IHC 1+ or IHC 2+/ISH–) breast cancer who have received endocrine-based therapy and at least two additional systemic therapies in the metastatic setting.
References
- Bardia A, Hurvitz SA, Tolaney SM, et al. Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer. N Engl J Med. 2021;384(16):1529-1541. doi:10.1056/NEJMoa2028485.
- Bardia A, Mayer IA, Vahdat LT, et al. Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer. N Engl J Med. 2019;380(8):741-751. doi:10.1056/NEJMoa1814213.
- U.S. FDA Approves Trodelvy in Pre-treated HR+/HER2- Metastatic Breast Cancer. Feb 03, 2023. https://www.drugs.com/newdrugs/u-s-fda-approves-trodelvy-pre-treated-hr-her2-metastatic-breast-cancer-5970.html
- Trodelvy Prescribing Information. https://www.gilead.com/-/media/files/pdfs/medicines/oncology/trodelvy/trodelvy_pi.pdf
Read next
What happens when you stop taking letrozole?
When you stop taking letrozole, side effects such as swelling, cough, hot flashes, and nausea, should improve within a week or 10 days. Some, such as high cholesterol, bone loss, and hair thinning may take many months to resolve. As long as you have taken it for at least 5 years, then letrozole should continue to reduce the risk of breast cancer coming back for many years after you stop taking it. Letrozole is usually taken for 5 years, but may be recommended for up to 10 years depending on individual circumstances. Continue reading
What is the success rate of Keytruda?
In general, PD-1 immune checkpoint inhibitors like Keytruda have been shown to significantly prolong overall survival (OS) in some patients with various cancer types, but Keytruda does not always work for everyone. Continue reading
How long does Ibrance extend life?
The length of time Ibrance may extend life depends on many factors, such as your overall health and other treatments. In combination with Faslodex (fulvestrant), Ibrance may extend overall survival by about 7 months compared to taking fulvestrant alone. Continue reading
See also:
Aimovig
Learn about Aimovig (erenumab-aooe) a once-monthly, injectable medication that can be ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Trodelvy
Trodelvy (sacituzumab govitecan) is a targeted therapy used to treat breast cancer (triple-negative ...
Nurtec ODT
Nurtec ODT (rimegepant) is used to treat acute migraines and prevent episodic migraines, by ...
Vyepti
Vyepti (eptinezumab-jjmr) is used for the preventive treatment of migraine. Includes Vyepti ...
Depakote
Depakote is used to treat various types of seizure disorders. Learn about side effects ...
Topamax
Topamax (topiramate) is used to prevent seizures in adults and children and to prevent migraine ...
Emgality
Emgality (galcanezumab-gnlm) is a CGRP antagonist for the preventive treatment of migraine and for ...
Inderal
Inderal (propranolol) is used to treat angina, high blood pressure and heart rhythm disorders ...
Related medical questions
- Does anastrozole cause hair loss?
- How do you relieve joint pain associated with tamoxifen or Aromasin?
- Is letrozole a form of chemotherapy?
- What does anastrozole do to your body?
- What are monoclonal antibodies?
- What is the TC chemo regimen and how does it treat breast cancer?
- What is the success rate of Enhertu in metastatic breast cancer?
- What is the lifetime or cumulative dose for Adriamycin?
- Why give Taxol (Paxel) before carboplatin?
- Does Femara make your hair fall out?
- What is Herceptin? Is Herceptin a chemo drug? How does it work?
- Does letrozole affect blood sugar levels?
- How does Adriamycin and Cytoxan (AC chemo) work for Breast Cancer?
- What is TCHP chemotherapy and how is it used?
- What is the success rate for Femara in breast cancer?
- Will insurance pay for the cost of Ibrance?
- Treatments for Menopause
- What are 10 key Ibrance side effects to watch out for?
- What are the long-term side effects of Adriamycin?
- Why do you need to take Xeloda with food?
- Is it common to lose hair AFTER stopping tamoxifen?
- Which is better - Aromasin or Femara?
- How long do you take Verzenio for?
- How long can you stay on Herceptin and Perjeta?
Drug information
- Trodelvy Information for Consumers
- Trodelvy prescribing info & package insert (for Health Professionals)
- Side Effects of Trodelvy (detailed)
- Trodelvy user reviews (4)
Related support groups
- Trodelvy (1 questions, 4 members)
- Breast Cancer (130 questions, 311 members)
- Urothelial Carcinoma (7 questions, 3 members)